Canakinumab Subcutaneous and Humalog 50/50
Determining the interaction of Canakinumab Subcutaneous and Humalog 50/50 and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: canakinumab
Brand name: Ilaris
Synonyms: Canakinumab
Generic Name: insulin lispro
Brand name: Admelog, Humalog, HumaLOG Pen, HumaLOG KwikPen, HumaLOG Cartridge, HumaLOG Junior KwikPen, Admelog SoloStar, Humalog
Synonyms: Insulin lispro, Insulin Lispro
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Canakinumab Subcutaneous-HumaLOG KwikPen
- Canakinumab Subcutaneous-Humalog Mix
- Canakinumab Subcutaneous-Humalog Mix 50/50
- Canakinumab Subcutaneous-Humalog Mix 50/50 (Insulin Lispro Protamine and Insulin Lispro (Pens))
- Canakinumab Subcutaneous-HumaLog Mix 50/50 (Insulin Lispro Protamine and Insulin Lispro (Vials))
- Canakinumab Subcutaneous-Humalog Mix 50/50 KwikPen
- Humalog 50/50-Canasa
- Humalog 50/50-Canasa Pac rectal
- Humalog 50/50-Canasa rectal
- Humalog 50/50-Cancidas
- Humalog 50/50-Candesartan
- Humalog 50/50-Candesartan and Hydrochlorothiazide